Document Detail


Mitochondrial KATP opening confers protection against lethal myocardial injury and ischaemia-induced arrhythmias in the rat heart via PI3K/Akt-dependent and -independent mechanisms.
MedLine Citation:
PMID:  20029542     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Opening of mitochondrial KATP channels (mitoKATP) has been reported to underlie protection against ischaemia-reperfusion injury induced by ischaemic preconditioning (I-PC); however, the molecular mechanisms of its antiarrhythmic effect have not been fully elucidated. We explored the involvement of phosphatidylinositol 3-kinase (PI3K)/Akt in the PC-like effect of mitoKATP opener diazoxide with particular regard to its role in protection against ischaemia-induced arrhythmias. Langendorff-perfused rat hearts were subjected to 30 min LAD occlusion with or without a prior 15 min of perfusion with diazoxide (50 micromol/L) given either alone (D-PC) or in combination with the PI3K/Akt inhibitor wortmannin (100 nmol/L). In an additional protocol, ischaemia was followed by 2 h reperfusion for infarct size (IS) determination (tetrazolium staining). The total number of premature ventricular complexes over the whole period of ischaemia, episodes of ventricular tachycardia and its duration were significantly lower in the D-PC group than in the non-preconditioned controls (158 +/- 20, 2 +/- 0.6 and 4.6 +/- 1.8 s vs. 551 +/- 61, 11 +/- 2 and 42 +/- 8 s, respectively; p < 0.05), concomitant with a 62% reduction in the size of infarction. Wortmannin modified neither arrhythmogenesis nor IS in the non-preconditioned hearts. Bracketing of diazoxide with wortmannin did not reverse the antiarrhythmic protection, whereas the IS-limiting effect was blunted. The results indicate that in contrast with the positive role of PI3K/Akt in protection against lethal myocardial injury, its activity is not involved in suppression of ischaemia-induced arrhythmias conferred by mitoKATP opening in the rat heart.
Authors:
Jana Matej?kov?; T?na Ravingerov?; Dezider Pancza; Sl?vka Carnick?; Frantisek Kol?r
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Canadian journal of physiology and pharmacology     Volume:  87     ISSN:  1205-7541     ISO Abbreviation:  Can. J. Physiol. Pharmacol.     Publication Date:  2009 Dec 
Date Detail:
Created Date:  2009-12-23     Completed Date:  2010-03-01     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372712     Medline TA:  Can J Physiol Pharmacol     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  1055-62     Citation Subset:  IM    
Affiliation:
Institute for Heart Research, Slovak Academy of Sciences, Centre of Excellence for Cardiovascular Research, Bratislava, Slovak Republic. usrdjama@savba.sk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
1-Phosphatidylinositol 3-Kinase / drug effects,  physiology*
Androstadienes / pharmacology
Animals
Arrhythmias, Cardiac / drug therapy,  physiopathology*
Diazoxide / pharmacology
Mitochondria, Heart / physiology*
Myocardial Ischemia / drug therapy,  physiopathology*
Myocardial Reperfusion Injury / drug therapy,  physiopathology*
Potassium Channels / physiology*
Protein Kinase Inhibitors / pharmacology
Proto-Oncogene Proteins c-akt / drug effects,  physiology*
Rats
Rats, Wistar
Vasodilator Agents / pharmacology
Chemical
Reg. No./Substance:
0/Androstadienes; 0/Potassium Channels; 0/Protein Kinase Inhibitors; 0/Vasodilator Agents; 0/mitochondrial K(ATP) channel; 19545-26-7/wortmannin; 364-98-7/Diazoxide; EC 2.7.1.137/1-Phosphatidylinositol 3-Kinase; EC 2.7.11.1/Proto-Oncogene Proteins c-akt

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Dual effect of polyphenolic compounds on cardiac Na+/K+-ATPase during development and persistence of...
Next Document:  Omega-3E treatment regulates matrix metalloproteinases and prevents vascular reactivity alterations ...